Clinical Study

Impact of Previous ART and of ART Initiation on Outcome of HIV-Associated Tuberculosis

Table 3

Univariable and multivariable mortality rate ratio (MRR)* for 246 HIV-infected patients with tuberculosis.

VariableUnivariable analysisMultivariable analysis
MRR (95% CI) valueMRR (95% CI) value

Sex
 Male1.001.00
 Female0.52 (0.18–1.47)0.2170.46 (0.15–1.38)0.163
Place of origin
 Born in Italy1.001.00
 Foreign born0.50 (0.22–1.15)0.1021.36 (0.42–4.41)0.608
Age at TB diagnosis
 <401.001.00
 ≥401.96 (1.02–3.77)0.0432.73 (1.26–5.93)0.011
Education (years)
 0–81.001.00
 9–181.14 (0.52–2.50)0.7360.92 (0.39–2.21)0.855
 Unknown0.81 (0.33–2.02)0.6591.00 (0.36–2.76)0.999
History of imprisonment
 Yes1.001.00
 No/unknown0.80 (0.28–2.26)0.6752.05 (0.64–6.60)0.282
Mode of HIV infection
 IDU1.001.00
 Other0.37 (0.18–0.75)0.0060.39 (0.15–0.99)0.047
Housing
 Private1.001.00
 Community/homeless0.71 (0.22–2.32)0.5730.29 (0.07–1.17)0.082
CD4 lymphocyte count (per 50 cells increase)0.85 (0.75–0.96)0.0100.83 (0.72–0.95)0.006
AIDS
 Yes1.001.00
 No0.40 (0.19–0.85)0.0170.47 (0.20–1.13)0.091
Site of diseases
 Pulmonary1.001.00
 Extra pulmonary0.94 (0.43–2.07)0.8881.36 (0.59–3.11)0.471
History of TB treatment
 New cases1.001.00
 Previously treated cases1.53 (0.70–3.35)0.2920.78 (0.32–1.94)0.597
Drug susceptibility test
 Susceptible TB1.001.00
 DR TB0.48 (0.11–2.12)0.3360.34 (0.07–1.68)0.184
 MDR TB3.91 (0.90–17.12)0.07035.50 (5.50–229.19)<0.001
 Not available0.85 (0.43–1.71)0.6581.34 (0.60–3.00)0.471
Awareness of HIV seropositivity and HIV treatment history
 Not aware1.001.00
 Aware and ART-naive2.64 (0.92–7.60)0.0721.73 (0.52–5.72)0.370
 Not ART-naive3.41 (1.28–9.08)0.0144.27 (1.27–14.29)0.019
cART (time dependent)
 No1.001.00
 Yes0.26 (0.13–0.52)<0.0010.14 (0.06–0.30)<0.001
Concomitant diseases at TB diagnosis
 Yes1.001.00
 No0.43 (0.22–0.83)0.0120.63 (0.29–1.35)0.231

*Estimated by a Poisson regression model.